FINDEX Inc. (TSE:3649) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

FINDEX Inc. (TSE:3649) shares have had a horrible month, losing 26% after a relatively good period beforehand. The drop over the last 30 days has capped off a tough year for shareholders, with the share price down 45% in that time.

In spite of the heavy fall in price, FINDEX's price-to-earnings (or "P/E") ratio of 15.2x might still make it look like a sell right now compared to the market in Japan, where around half of the companies have P/E ratios below 13x and even P/E's below 9x are quite common. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the elevated P/E.

Recent earnings growth for FINDEX has been in line with the market. It might be that many expect the mediocre earnings performance to strengthen positively, which has kept the P/E from falling. You'd really hope so, otherwise you're paying a pretty hefty price for no particular reason.

Check out our latest analysis for FINDEX

pe-multiple-vs-industry
TSE:3649 Price to Earnings Ratio vs Industry March 6th 2025
If you'd like to see what analysts are forecasting going forward, you should check out our free report on FINDEX.
Advertisement

How Is FINDEX's Growth Trending?

The only time you'd be truly comfortable seeing a P/E as high as FINDEX's is when the company's growth is on track to outshine the market.

If we review the last year of earnings growth, the company posted a worthy increase of 9.7%. The latest three year period has also seen an excellent 82% overall rise in EPS, aided somewhat by its short-term performance. So we can start by confirming that the company has done a great job of growing earnings over that time.

Turning to the outlook, the next year should generate growth of 12% as estimated by the only analyst watching the company. With the market predicted to deliver 10% growth , the company is positioned for a comparable earnings result.

In light of this, it's curious that FINDEX's P/E sits above the majority of other companies. It seems most investors are ignoring the fairly average growth expectations and are willing to pay up for exposure to the stock. These shareholders may be setting themselves up for disappointment if the P/E falls to levels more in line with the growth outlook.

The Final Word

FINDEX's P/E hasn't come down all the way after its stock plunged. It's argued the price-to-earnings ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

We've established that FINDEX currently trades on a higher than expected P/E since its forecast growth is only in line with the wider market. Right now we are uncomfortable with the relatively high share price as the predicted future earnings aren't likely to support such positive sentiment for long. This places shareholders' investments at risk and potential investors in danger of paying an unnecessary premium.

It is also worth noting that we have found 1 warning sign for FINDEX that you need to take into consideration.

If P/E ratios interest you, you may wish to see this free collection of other companies with strong earnings growth and low P/E ratios.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:3649

FINDEX

Offers medical systems, office systems, and medical equipment solutions in Japan.

Flawless balance sheet with reasonable growth potential.

Advertisement

Weekly Picks

JO
Jolt_Communications
MYSE logo
Jolt_Communications on Myseum ·

The Future of Social Sharing Is Private and People Are Ready

Fair Value:US$7.9577.1% undervalued
19 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TO
Tokyo
ASML logo
Tokyo on ASML Holding ·

EU#3 - From Philips Management Buyout to Europe’s Biggest Company

Fair Value:€1.31k7.1% undervalued
26 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative
YI
BKNG logo
yiannisz on Booking Holdings ·

Booking Holdings: Why Ground-Level Travel Trends Still Favor the Platform Giants

Fair Value:US$5.47k8.5% undervalued
6 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
CO
composite32
SHEL logo
composite32 on Shell ·

A fully integrated LNG business seems to be ignored by the market.

Fair Value:UK£36.122.6% undervalued
35 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

BL
BlackGoat
PLTR logo
BlackGoat on Palantir Technologies ·

Palantir: Redefining Enterprise Software for the AI Era

Fair Value:US$107.0237.0% overvalued
194 users have followed this narrative
6 users have commented on this narrative
1 users have liked this narrative
AN
andre_santos
MSFT logo
andre_santos on Microsoft ·

Microsoft - A Fundamental and Historical Valuation

Fair Value:US$437.171.6% undervalued
17 users have followed this narrative
4 users have commented on this narrative
0 users have liked this narrative
UN
unknown
MRK logo
unknown on Merck ·

The Oncology Anchor: Why Merck’s 46% Discount Defies the Keytruda Cliff

Fair Value:US$201.5645.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OO
NEO logo
OOO97 on Neo Performance Materials ·

Undervalued Key Player in Magnets/Rare Earth

Fair Value:CA$25.3324.4% undervalued
71 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0224.5% undervalued
1047 users have followed this narrative
6 users have commented on this narrative
31 users have liked this narrative
AN
AnalystConsensusTarget
AMZN logo
AnalystConsensusTarget on Amazon.com ·

AMZN: Acceleration In Cloud And AI Will Drive Margin Expansion Ahead

Fair Value:US$295.6119.1% undervalued
1342 users have followed this narrative
5 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

JA
jayhcee
MPAA logo
jayhcee on Motorcar Parts of America ·

MPAA often has inventory and core-related timing issues. While this quarter’s problems may ease, similar issues have recurred historically and can persist for several quarters. It's not a one-off, it's a structural part of their business. Core returns are simply estimates: How many customers will actually return the original part; how quickly they'll do so; how many are useable; what they're worth, etc. MPAA predicts X sales in a quarter and Y core returns and its reserves, inventory values, etc. are based on that. If they expect a 90% core return rate and only 80% come back it doesn't change cash but they have to write down inventory and increase cost of goods sold which impacts EPS. They've also cited inventory buildup at key customers multiple times in the past. The assumption the latest backlog will all shift into future quarters this year with no impact on pricing, etc. seems more like wishful thinking. Retailer X was slated to buy $10m in parts this quarter but finds they have a lot more inventory on hand than they anticipated so they pushed the order. Realistically there are likely to be SKU cuts, reduction in safety stock on others, etc. Assuming that all $10m will come in this year plus the regular replenishment seems pretty unrealistic. MPAA also has a shaky track record when it comes to new lines and the supposed impact on business. If you look at the EV testing solutions hype back around 2020 that was supposed to diversify them beyond traditional reman and be a higher margin business that would grow with EV adoption. But it has never turned into a material contributor. The debt reduction and stock buy backs are meaningful but IMHO this narrative takes a very optimistic view of things.

0
|
0
Advertisement